Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
will be based in Odense, under the primary supervision of Prof. Ricardo J. G. B. Campello , but they will be expected to also work closely with other PhD students, postdocs, and collaborators both from
-
decisions about personalised phage therapy. The expected workload is mainly computational, using bioinformatics analyses to investigate the microbiome and phageome with supporting laboratory work for DNA
-
. The successful candidate will be based in Odense, under the primary supervision of Prof. Ricardo J. G. B. Campello , but they will be expected to also work closely with other PhD students, postdocs, and
-
Association. Our institute integrates cutting-edge biomolecular research, bioinformatics, and high-performance analytical technologies to explore the complex interactions between the human organism and food
-
(locomotor activity, ultrasonic vocalizations) and molecular profiling (qRT-PCR, NGS). An integrative bioinformatics approach will be used to identify molecular networks involved in addiction-related processes
-
18.11.2025 Application deadline: 19.01.2026 Prof. Boris Macek advertises a PhD position (m/f/d) in his group at University of Tübingen, Germany. This PhD position is a part of the BUG-ID Marie
-
Cancer Consortium (DKTK). The Institute of Translational Cancer Research and Experimental Cancer Therapy (headed by Prof. Dr. Dieter Saur) at the DKTK partner site Munich is offering for the next possible
-
methodologies including, DNA isolation, library preparation and sequencing as well as bioinformatic skills to analyse the acquired sequencing data. The project will be supervised by Dr Hellmich and Prof Rushworth
-
with university partners at seven renowned partner sites, we have established the German Cancer Consortium (DKTK). The Institute of Translational Cancer Research and Experimental Cancer Therapy (headed by Prof. Dr
-
with university partners at seven renowned partner sites, we have established the German Cancer Consortium (DKTK). The Institute of Translational Cancer Research and Experimental Cancer Therapy (headed by Prof. Dr